ClearPoint Neuro (CLPT)
(Real Time Quote from BATS)
$5.34 USD
+0.01 (0.19%)
Updated Apr 30, 2024 12:06 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Cash flow Statements
Fiscal Year End for ClearPoint Neuro, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -22.09 | -16.44 | -14.41 | -6.78 | -5.54 |
Depreciation/Amortization & Depletion | 1.51 | 0.83 | 0.79 | 1.44 | 0.98 |
Net Change from Assets/Liabilities | -0.36 | -4.29 | -1.68 | -2.66 | 0.91 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.21 | 3.73 | 2.61 | 0.20 | 0.80 |
Net Cash From Operating Activities | -13.72 | -16.17 | -12.70 | -7.81 | -2.85 |
Property & Equipment | -0.72 | -0.25 | -0.17 | -0.04 | -0.01 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 10.00 | -9.59 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.33 | -0.89 | 0.00 | -0.44 | -0.15 |
Net Cash from Investing Activities | 8.95 | -10.74 | -0.17 | -0.48 | -0.16 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.51 | 0.75 | 47.47 | 0.38 | 0.39 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 22.32 | -2.14 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.21 | -0.34 | -0.60 | 0.00 | 7.35 |
Net Cash from Financing Activities | 0.30 | 0.41 | 46.88 | 22.69 | 5.60 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -4.48 | -26.49 | 34.01 | 14.40 | 2.59 |
Cash at Beginning of Period | 27.62 | 54.11 | 20.10 | 5.70 | 3.10 |
Cash at End of Period | 23.14 | 27.62 | 54.11 | 20.10 | 5.70 |
Diluted Net EPS | -0.90 | -0.68 | -0.69 | -0.43 | -0.42 |
Fiscal Year End for ClearPoint Neuro, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -22.09 | -17.47 | -12.66 | -5.61 |
Depreciation/Amortization & Depletion | NA | 1.51 | 1.08 | 0.64 | 0.29 |
Net Change from Assets/Liabilities | NA | -0.36 | -1.47 | -2.01 | -1.77 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 7.21 | 5.31 | 3.28 | 1.41 |
Net Cash From Operating Activities | NA | -13.72 | -12.55 | -10.76 | -5.68 |
Property & Equipment | NA | -0.72 | -0.70 | -0.46 | -0.14 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 10.00 | 10.00 | 10.00 | 0.00 |
Other Investing Activities | NA | -0.33 | -0.17 | -0.17 | 0.00 |
Net Cash from Investing Activities | NA | 8.95 | 9.14 | 9.37 | -0.14 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.51 | 0.31 | 0.31 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.21 | -0.17 | -0.08 | -0.01 |
Net Cash from Financing Activities | NA | 0.30 | 0.14 | 0.23 | -0.01 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -4.48 | -3.27 | -1.15 | -5.82 |
Cash at Beginning of Period | NA | 27.62 | 27.62 | 27.62 | 27.62 |
Cash at End of Period | NA | 23.14 | 24.34 | 26.46 | 21.79 |
Diluted Net EPS | NA | -0.18 | -0.20 | -0.29 | -0.23 |